Furthermore, serum GP73 demonstrated excellent performance in distinguishing HBV‐ACLF from CHB and LC, with an area under the curve of 0.969 and 0.824, respectively. The gene discussed is GOLM1; the disease is laryngotracheoesophageal cleft.